| Year |
Citation |
Score |
| 2023 |
Nagy Á, Bátai B, Kiss L, Gróf S, Király PA, Jóna Á, Demeter J, Sánta H, Bátai Á, Pettendi P, Szendrei T, Plander M, Körösmezey G, Alizadeh H, Kajtár B, ... ... Matolcsy A, et al. Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma. Journal of Internal Medicine. PMID 37259686 DOI: 10.1111/joim.13674 |
0.691 |
|
| 2023 |
Krizsán S, Péterffy B, Egyed B, Nagy T, Sebestyén E, Hegyi LL, Jakab Z, Erdélyi DJ, Müller J, Péter G, Csanádi K, Kállay K, Kriván G, Barna G, Bedics G, ... ... Matolcsy A, et al. NEXT-GENERATION SEQUENCING-BASED GENOMIC PROFILING OF CHILDREN WITH ACUTE MYELOID LEUKEMIA. The Journal of Molecular Diagnostics : Jmd. PMID 37088137 DOI: 10.1016/j.jmoldx.2023.04.004 |
0.725 |
|
| 2021 |
Gángó A, Kiss R, Farkas P, Hanna E, Demeter J, Deák B, Lévai D, Kotmayer L, Alpár D, Matolcsy A, Bödör C, Mátrai Z, Timár B. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax. Pathology. PMID 34332791 DOI: 10.1016/j.pathol.2021.04.008 |
0.71 |
|
| 2021 |
Czeti Á, Szalóki G, Varga G, Szita VR, Komlósi ZI, Takács F, Márk Á, Timár B, Matolcsy A, Barna G. Limitations of VS38c labeling in the detection of plasma cell myeloma by flow cytometry. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 34296508 DOI: 10.1002/cyto.a.24488 |
0.68 |
|
| 2020 |
Csernus B, Timár B, Fülöp Z, Matolcsy A. Grade I, II and III Follicular Lymphomas Express Ig V Genes with Different Patterns of Somatic Mutation. Pathology Oncology Research : Por. PMID 32705429 DOI: 10.1007/S12253-020-00843-X |
0.793 |
|
| 2020 |
Nagy Á, Bátai B, Balogh A, Illés S, Mikala G, Nagy N, Kiss L, Kotmayer L, Matolcsy A, Alpár D, Masszi T, Masszi A, Bödör C. Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma. Genes. 11. PMID 32668764 DOI: 10.3390/Genes11070785 |
0.391 |
|
| 2019 |
Bödör C, Alpár D, Marosvári D, Galik B, Rajnai H, Bátai B, Nagy Á, Kajtár B, Burján A, Deák B, Schneider T, Alizadeh H, Matolcsy A, Brandner S, Storhoff J, et al. Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma. Journal of Neuropathology and Experimental Neurology. PMID 31886867 DOI: 10.1093/Jnen/Nlz125 |
0.509 |
|
| 2019 |
Kiss R, Gángó A, Benard-Slagter A, Egyed B, Haltrich I, Hegyi L, de Groot K, Király PA, Krizsán S, Kajtár B, Pikó H, Pajor L, Vojcek Á, Matolcsy A, Kovács G, et al. Comprehensive profiling of disease-relevant copy number aberrations for advanced clinical diagnostics of pediatric acute lymphoblastic leukemia. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31857684 DOI: 10.1038/S41379-019-0423-5 |
0.43 |
|
| 2019 |
Gángó A, Alpár D, Galik B, Marosvári D, Kiss R, Fésüs V, Aczél D, Eyüpoglu E, Nagy N, Nagy Á, Krizsán S, Reiniger L, Farkas P, Kozma A, Ádám E, ... ... Matolcsy A, et al. Dissection of Subclonal Evolution by Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated With Ibrutinib. International Journal of Cancer. PMID 31180577 DOI: 10.1016/J.Clml.2019.07.214 |
0.431 |
|
| 2019 |
Alpár D, Kiss R, Gángó A, Benard-Slagter A, Egyed B, Haltrich I, Hegyi L, de Groot K, Király PA, Krizsán S, Kajtár B, Pikó H, Pajor L, Vojcek Á, Matolcsy A, et al. Comprehensive Profiling of Disease-Relevant Copy Number Aberrations Improves Risk Assessment and Unveils the Clonal Origin of Relapse in Pediatric Acute Lymphoblastic Leukemia Blood. 134: 1474-1474. DOI: 10.1182/Blood-2019-128699 |
0.445 |
|
| 2018 |
Mózes R, Gángó A, Sulák A, Vida L, Reiniger L, Timár B, Krenács T, Alizadeh H, Masszi T, Gaál-Weisinger J, Demeter J, Csomor J, Matolcsy A, Kajtár B, Bödör C. Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms. Pathology. PMID 30606612 DOI: 10.1016/J.Pathol.2018.11.007 |
0.707 |
|
| 2018 |
Takács F, Tolnai-Kriston C, Hernádfői M, Szabó O, Szalóki G, Szepesi Á, Czeti Á, Matolcsy A, Barna G. The Effect of CD86 Expression on the Proliferation and the Survival of CLL Cells. Pathology Oncology Research : Por. PMID 30406401 DOI: 10.1007/S12253-018-0512-7 |
0.322 |
|
| 2018 |
Kiss R, Alpár D, Gángó A, Nagy N, Eyupoglu E, Aczél D, Matolcsy A, Csomor J, Mátrai Z, Bödör C. Spatial clonal evolution leading to ibrutinib resistance and disease progression in chronic lymphocytic leukemia. Haematologica. PMID 30262564 DOI: 10.3324/Haematol.2018.202085 |
0.368 |
|
| 2018 |
Kosztolanyi S, Kiss R, Atanesyan L, Gango A, de Groot K, Steenkamer M, Jakso P, Matolcsy A, Kajtar B, Pajor L, Szuhai K, Savola S, Bodor C, Alpar D. High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma. The Journal of Molecular Diagnostics : Jmd. PMID 30096382 DOI: 10.1016/J.Jmoldx.2018.06.004 |
0.396 |
|
| 2018 |
Szurián K, Csala I, Marosvári D, Rajnai H, Dezső K, Bödör C, Piurkó V, Matolcsy A, Reiniger L. EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes. Experimental and Molecular Pathology. 105: 161-165. PMID 30031020 DOI: 10.1016/J.Yexmp.2018.07.009 |
0.373 |
|
| 2018 |
Kriston C, Plander M, Márk Á, Sebestyén A, Bugyik E, Matolcsy A, Barna G. In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment. Annals of Hematology. PMID 29955944 DOI: 10.1007/S00277-018-3410-X |
0.393 |
|
| 2018 |
Gángó A, Bátai B, Varga M, Kapczár D, Papp G, Marschalkó M, Kuroli E, Schneider T, Csomor J, Matolcsy A, Bödör C, Szepesi Á. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein. Virchows Archiv : An International Journal of Pathology. PMID 29858685 DOI: 10.1007/S00428-018-2384-3 |
0.486 |
|
| 2018 |
Gángó A, Mózes R, Boha Z, Kajtár B, Timár B, Király PA, Kiss R, Fésüs V, Nagy N, Demeter J, Körösmezey G, Borbényi Z, Marton I, Szőke A, Masszi T, ... ... Matolcsy A, et al. Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms. Leukemia Research. 65: 42-48. PMID 29306106 DOI: 10.1016/J.Leukres.2017.12.005 |
0.715 |
|
| 2018 |
Kiss R, Alpár D, Gángó A, Nagy N, Aczel D, Matolcsy A, Csomor J, Mátrai Z, Bödör C. Spatial Convergent Clonal Evolution Leading to Ibrutinib Resistance and Disease Progression in Chronic Lymphocytic Leukemia Blood. 132: 5539-5539. DOI: 10.1182/Blood-2018-99-115937 |
0.443 |
|
| 2018 |
Bátai B, Gángó A, Varga M, Kapczár D, Papp G, Marschalkó M, Kuroli E, Schneider T, Csomor J, Matolcsy A, Bödör C, Szepesi Á. 1p36 deletion is associated with TNFRSF14 mutations in primary cutaneous follicle center lymphoma European Journal of Cancer. 101: S11. DOI: 10.1016/J.Ejca.2018.07.170 |
0.396 |
|
| 2017 |
Tawana K, Wang J, Király PA, Kállay K, Benyó G, Zombori M, Csomor J, Al Seraihi A, Rio-Machin A, Matolcsy A, Chelala C, Cavenagh J, Fitzgibbon J, Bödör C. Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree. European Journal of Human Genetics : Ejhg. PMID 28513614 DOI: 10.1038/Ejhg.2017.80 |
0.397 |
|
| 2017 |
Király AP, Kállay K, Gángó A, Kellner Á, Egyed M, Szőke A, Kiss R, Vályi-Nagy I, Csomor J, Matolcsy A, Bödör C. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary. Pathology Oncology Research : Por. PMID 28357685 DOI: 10.1007/S12253-017-0216-4 |
0.403 |
|
| 2017 |
Barna G, Tolnai-Kriston C, Hernádfői M, Plander M, Takács F, Matolcsy A. THE EFFECT OF AN IMMUNOMODULATORY DRUG ON THE VIABILITY AND SURFACE MOLECULE EXPRESSION OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS Hematological Oncology. 35: 403-403. DOI: 10.1002/Hon.2439_178 |
0.314 |
|
| 2016 |
Márk Á, Varga G, Timár B, Kriston C, Szabó O, Deák L, Matolcsy A, Barna G. The effect of microenvironmental factors on the development of myeloma cells. Hematological Oncology. PMID 27766647 DOI: 10.1002/Hon.2354 |
0.706 |
|
| 2016 |
Misra S, Selvam AK, Wallenberg M, Ambati A, Matolcsy A, Magalhaes I, Lauter G, Björnstedt M. Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget. PMID 27732960 DOI: 10.18632/Oncotarget.12531 |
0.363 |
|
| 2016 |
Marschalkó M, Gyöngyösi N, Noll J, Károlyi Z, Wikonkál N, Hársing J, Kuroli E, Csomor J, Matolcsy A, Sarolta K, Szepesi Á. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis. Journal of Cutaneous Pathology. PMID 27461449 DOI: 10.1111/Cup.12779 |
0.371 |
|
| 2016 |
Érsek B, Lupsa N, Pócza P, Tóth A, Horváth A, Molnár V, Bagita B, Bencsik A, Hegyesi H, Matolcsy A, Buzás EI, Pós Z. Unique patterns of CD8+ T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease. Cellular and Molecular Life Sciences : Cmls. PMID 27137185 DOI: 10.1007/S00018-016-2237-7 |
0.333 |
|
| 2015 |
Kriston C, Bödör C, Szenthe K, Bánáti F, Bánkuti B, Csernus B, Reiniger L, Csomor J, Matolcsy A, Barna G. Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL. Hematological Oncology. PMID 26119874 DOI: 10.1002/Hon.2244 |
0.313 |
|
| 2015 |
Rajnai H, Teleki I, Kiszner G, Meggyesházi N, Balla P, Vancsik T, Muzes G, Csomor J, Matolcsy A, Krenacs T. Connexin 43 communication channels in follicular dendritic cell development and in follicular lymphomas. Journal of Immunology Research. 2015: 528098. PMID 25815348 DOI: 10.1155/2015/528098 |
0.403 |
|
| 2014 |
Marschalkó M, Erős N, Kontár O, Hidvégi B, Telek J, Hársing J, Jókai H, Bottlik G, Rajnai H, Szepesi Á, Matolcsy A, Kárpáti S, Csomor J. Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients. Journal of the European Academy of Dermatology and Venereology : Jeadv. 29: 964-72. PMID 25406034 DOI: 10.1111/Jdv.12743 |
0.337 |
|
| 2014 |
Saft L, Karimi M, Ghaderi M, Matolcsy A, Mufti GJ, Kulasekararaj A, Göhring G, Giagounidis A, Selleslag D, Muus P, Sanz G, Mittelman M, Bowen D, Porwit A, Fu T, et al. p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q). Haematologica. 99: 1041-9. PMID 24682512 DOI: 10.3324/Haematol.2013.098103 |
0.369 |
|
| 2014 |
Okosun J, Bödör C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D, Bozek M, Iqbal S, Matthews J, Wrench D, Marzec J, Tawana K, Popov N, ... ... Matolcsy A, et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nature Genetics. 46: 176-81. PMID 24362818 DOI: 10.1038/Ng.2856 |
0.462 |
|
| 2014 |
Rajnai H, Heyning FH, Koens L, Sebestyén A, Andrikovics H, Hogendoorn PC, Matolcsy A, Szepesi Á. The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone. Virchows Archiv : An International Journal of Pathology. 464: 229-39. PMID 24306958 DOI: 10.1007/S00428-013-1519-9 |
0.459 |
|
| 2013 |
Beke A, Piko H, Haltrich I, Csomor J, Matolcsy A, Fekete G, Rigo J, Karcagi V. Molecular cytogenetic analysis of Xq critical regions in premature ovarian failure. Molecular Cytogenetics. 6: 62. PMID 24359613 DOI: 10.1186/1755-8166-6-62 |
0.339 |
|
| 2013 |
Bödör C, Grossmann V, Popov N, Okosun J, O'Riain C, Tan K, Marzec J, Araf S, Wang J, Lee AM, Clear A, Montoto S, Matthews J, Iqbal S, Rajnai H, ... ... Matolcsy A, et al. EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood. 122: 3165-8. PMID 24052547 DOI: 10.1182/Blood-2013-04-496893 |
0.396 |
|
| 2013 |
Boi M, Rinaldi A, Kwee I, Bonetti P, Todaro M, Tabbò F, Piva R, Rancoita PM, Matolcsy A, Timar B, Tousseyn T, RodrÃguez-Pinilla SM, Piris MA, Beà S, Campo E, et al. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood. 122: 2683-93. PMID 24004669 DOI: 10.1182/Blood-2013-04-497933 |
0.761 |
|
| 2013 |
Chigrinova E, Rinaldi A, Kwee I, Rossi D, Rancoita PM, Strefford JC, Oscier D, Stamatopoulos K, Papadaki T, Berger F, Young KH, Murray F, Rosenquist R, Greiner TC, Chan WC, ... ... Matolcsy A, et al. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood. 122: 2673-82. PMID 24004666 DOI: 10.1182/Blood-2013-03-489518 |
0.359 |
|
| 2013 |
Koens L, Heyning FH, Szepesi A, Matolcsy A, Hogendoorn PC, Jansen PM. Nuclear factor-κB activation in primary lymphoma of bone. Virchows Archiv : An International Journal of Pathology. 462: 349-54. PMID 23328932 DOI: 10.1007/S00428-013-1372-X |
0.406 |
|
| 2012 |
Gadó K, Matolcsy A, Csomor J, Kicsi D, Bödör C, Domján G. Long lasting complete molecular remission after suspending dasatinib treatment in chronic myeloid leukemia. Experimental Hematology & Oncology. 1: 17. PMID 23210842 DOI: 10.1186/2162-3619-1-17 |
0.3 |
|
| 2012 |
Szepesi Á, Csomor J, Rajnai H, Erős N, Wikonkál N, Kárpáti S, Matolcsy A, Marschalkó M. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease. European Journal of Dermatology : Ejd. 22: 690-1. PMID 22940730 DOI: 10.1684/Ejd.2012.1823 |
0.396 |
|
| 2012 |
Rajnai H, Bödör C, Balogh Z, Gagyi E, Csomor J, Krenács T, Tóth E, Matolcsy A. Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma. Histopathology. 60: E66-75. PMID 22394030 DOI: 10.1111/J.1365-2559.2012.04187.X |
0.763 |
|
| 2012 |
Bödör C, Renneville A, Smith M, Charazac A, Iqbal S, Etancelin P, Cavenagh J, Barnett MJ, Kramarzová K, Krishnan B, Matolcsy A, Preudhomme C, Fitzgibbon J, Owen C. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica. 97: 890-4. PMID 22271902 DOI: 10.3324/Haematol.2011.054361 |
0.389 |
|
| 2012 |
Böodöor C, Vera G, Kohlmann A, Tan K, Okosun J, Popov N, Araf S, Marzec J, O‘Riain C, Lee A, Clear AJ, Montoto S, Matthews J, Iqbal S, Rajnai H, ... ... Matolcsy A, et al. High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy Blood. 120: 545-545. DOI: 10.1182/Blood.V120.21.545.545 |
0.423 |
|
| 2012 |
Udvardy M, Rosta A, Gasztonyi Z, Borbenyi Z, Radvanyi G, Egyed M, Gasztonyi B, Losonczy H, Matolcsy A, Andrasfalvy AH, Schneider TJ. Immunochemotherapy As Induction (R-CHOP and R-HyperC-VAD/R-MA) in Mantle Cell Lymphoma, a Hungarian Multicenter Open Label Phase II Study (Rituximab [MabThera®] in Mantle Cell Lymphoma, REMENY) Blood. 120: 4889-4889. DOI: 10.1182/Blood.V120.21.4889.4889 |
0.335 |
|
| 2012 |
Okosun J, Bödör C, Wang J, Araf S, Marzec J, Iqbal S, Matthews J, Calaminici M, O'Riain C, O'Shea D, Carlotti E, Davies A, Wrench D, Matolcsy A, Lister TA, et al. Whole Genome Sequencing in Sequential Biopsies Reveals the Genetic Evolution of Follicular Lymphoma to Transformed Follicular Lymphoma Blood. 120: 145-145. DOI: 10.1182/Blood.V120.21.145.145 |
0.507 |
|
| 2012 |
Balogh ZB, Reiniger L, Rajnai H, Csomor J, Szepesi A, Balogh A, Deak L, Gagyi E, Bodor C, Matolcsy A. P1.17 High Rate of Genetic Abnormalities of Neoplastic Cells in Pseudofollicles of Cll Annals of Oncology. 23. DOI: 10.1016/S0923-7534(20)31308-9 |
0.795 |
|
| 2011 |
Schneider T, Tóth E, Lovey J, Molnár Z, Deák B, Várady E, Csomor J, Matolcsy A, Lengyel Z, Petri K, Gaudi I, Rosta A. [Standard CHOP immuno-chemotherapy for primary mediastinal lymphomas]. Orvosi Hetilap. 152: 735-42. PMID 21498163 DOI: 10.1556/Oh.2011.29091 |
0.326 |
|
| 2011 |
Balogh Z, Reiniger L, Rajnai H, Csomor J, Szepesi A, Balogh A, Deák L, Gagyi E, Bödör C, Matolcsy A. High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia. Leukemia & Lymphoma. 52: 1080-4. PMID 21417824 DOI: 10.3109/10428194.2011.555889 |
0.773 |
|
| 2011 |
Sápi Z, Füle T, Hajdu M, Matolcsy A, Moskovszky L, Márk A, Sebestyén A, Bodoky G. The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 20: 22-33. PMID 21326036 DOI: 10.1097/Pdm.0B013E3181Eb931B |
0.386 |
|
| 2011 |
Bödör C, O'Riain C, Wrench D, Matthews J, Iyengar S, Tayyib H, Calaminici M, Clear A, Iqbal S, Quentmeier H, Drexler HG, Montoto S, Lister AT, Gribben JG, Matolcsy A, et al. EZH2 Y641 mutations in follicular lymphoma. Leukemia. 25: 726-9. PMID 21233829 DOI: 10.1038/Leu.2010.311 |
0.395 |
|
| 2011 |
Demeter J, Istenes I, Fodor A, Paksi M, Dombi P, Valasinyószki E, Csomor J, Matolcsy A, Nagy ZG. Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma. Pathology Oncology Research : Por. 17: 141-3. PMID 20628840 DOI: 10.1007/S12253-010-9276-4 |
0.342 |
|
| 2011 |
Barna G, Mihalik R, Timár B, Tömböl J, Csende Z, Sebestyén A, Bödör C, Csernus B, Reiniger L, Peták I, Matolcsy A. ROR1 expression is not a unique marker of CLL. Hematological Oncology. 29: 17-21. PMID 20597086 DOI: 10.1002/Hon.948 |
0.743 |
|
| 2011 |
Boi M, Rinaldi A, Piva R, Rancoita PM, Bonetti P, Matolcsy A, Tousseyn T, Rodríguez-Pinilla SM, Piris M, Beà S, Campo E, Bhagat G, Swerdlow SH, Rosenwald A, Ponzoni M, et al. BLIMP1 Is Commonly Inactivated In Anaplastic Large T-Cell Lymphomas (ALCL) Blood. 118: 2634-2634. DOI: 10.1182/Blood.V118.21.2634.2634 |
0.447 |
|
| 2010 |
Marschalkó M, Eros N, Holló P, Hársing J, Bottlik G, Bátai A, Csukly Z, Masszi T, Szentirmai Z, Fodor J, Kárpáti S, Matolcsy A, Csomor J. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration. The American Journal of Dermatopathology. 32: 708-12. PMID 20644462 DOI: 10.1097/Dad.0B013E3181D46Eba |
0.419 |
|
| 2010 |
Eros N, Marschalkó M, Balassa K, Hídvégi B, Szakonyi J, Ilniczky S, Borka K, Kovács A, Bottlik G, Hársing J, Csomor J, Szepesi A, Matolcsy A, Kárpáti S, Demeter J. Central nervous system involvement in CD4+/CD56+ hematodermic neoplasm: a report of two cases. Journal of Neuro-Oncology. 97: 301-4. PMID 19798469 DOI: 10.1007/S11060-009-0026-Y |
0.345 |
|
| 2010 |
Szepesi Á, Erõs N, Tímár B, Horváth B, Matolcsy A, Csomor J. 32 Intravascular large B-cell lymphoma: clinicopathological study of seven cases European Journal of Cancer Supplements. 8: 19. DOI: 10.1016/S1359-6349(10)70703-5 |
0.739 |
|
| 2009 |
Schneider T, Molnár Z, Deák B, Várady E, Tóth E, Csomor J, Matolcsy A, Lovey J, Lengyel Z, Petri K, Gaudi I, Rosta A. [Results of immuno-chemotherapeutic treatment of patients with diffuse large B-cell lymphoma]. Orvosi Hetilap. 150: 2019-26. PMID 19861288 DOI: 10.1556/Oh.2009.28726 |
0.313 |
|
| 2009 |
Horváth B, Demeter J, Eros N, Hársing J, Csomor J, Matolcsy A, Bottlik G, Gyori G, Marschalkó M, Kárpáti S. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy. Journal of the American Academy of Dermatology. 61: 885-8. PMID 19632742 DOI: 10.1016/J.Jaad.2008.12.045 |
0.457 |
|
| 2009 |
Fodor A, Molnar MZ, Krenacs L, Bagdi E, Csomor J, Matolcsy A, Demeter J. Autoimmune hemolytic anemia as a risk factor of poor outcome in patients with splenic marginal zone lymphoma. Pathology Oncology Research : Por. 15: 597-603. PMID 19343544 DOI: 10.1007/S12253-009-9159-8 |
0.335 |
|
| 2009 |
Fazakas Á, Csire M, Berencsi G, Szepesi Á, Matolcsy A, Jakab L, Kará I, Várkonyi J. Erratum: Original article: Clinical (Leukemia & Lymphoma (2009) 50:10 (1661-1665)) Leukemia & Lymphoma. 50. DOI: 10.3109/10428190903508171 |
0.338 |
|
| 2008 |
Gagyi E, Balogh Z, Bödör C, Timár B, Reiniger L, Deák L, Csomor J, Csernus B, Szepesi A, Matolcsy A. Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression. Haematologica. 93: 1822-8. PMID 18945749 DOI: 10.3324/Haematol.13239 |
0.761 |
|
| 2008 |
Erõs N, Marschalkó M, Lõrincz A, Hársing J, Csomor J, Szepesi A, Matolcsy A, Kárpáti S. CD30-positive anaplastic large T-cell lymphoma of the tongue. Journal of the European Academy of Dermatology and Venereology : Jeadv. 23: 231-2. PMID 18637863 DOI: 10.1111/J.1468-3083.2008.02821.X |
0.332 |
|
| 2008 |
Csomor J, Bognár A, Benedek S, Sinkó J, Fekete S, Krenács L, Matolcsy A, Reiniger L. Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman. Journal of Clinical Pathology. 61: 770-2. PMID 18505891 DOI: 10.1136/Jcp.2007.054585 |
0.406 |
|
| 2008 |
Eros N, Károlyi Z, Marschalkó M, Kárpáti S, Matolcsy A. Clinical, histopathological, immunophenotypic and molecular analysis of 60 patients with cutaneous T-cell infiltrates with follow up of indeterminate cases to identify T-cell lymphoma. Pathology Oncology Research : Por. 14: 63-7. PMID 18392954 DOI: 10.1007/S12253-008-9014-3 |
0.42 |
|
| 2008 |
Barna G, Reiniger L, Tátrai P, Kopper L, Matolcsy A. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL. Hematological Oncology. 26: 167-70. PMID 18381689 DOI: 10.1002/Hon.855 |
0.31 |
|
| 2007 |
Marschalkó M, Csomor J, Eros N, Szigeti A, Hársing J, Szakonyi J, Désaknai M, Matolcsy A, Demeter J, Kárpáti S. Coexistence of primary cutaneous anaplastic large cell lymphoma and mycosis fungoides in a patient with B-cell chronic lymphocytic leukaemia. The British Journal of Dermatology. 157: 1291-3. PMID 17927791 DOI: 10.1111/J.1365-2133.2007.08226.X |
0.43 |
|
| 2007 |
Gömöri E, Pál J, Mészáros I, Dóczi T, Matolcsy A. Epigenetic inactivation of the hMLH1 gene in progression of gliomas. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 16: 104-7. PMID 17525680 DOI: 10.1097/Pdm.0B013E318033F140 |
0.398 |
|
| 2007 |
Balogh Z, Reiniger L, Deák L, Bödör C, Csomor J, Szepesi A, Gagyi E, Kopper L, Matolcsy A. IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL). Hematological Oncology. 25: 90-5. PMID 17410523 DOI: 10.1002/Hon.812 |
0.79 |
|
| 2007 |
Várkonyi J, Jánosy J, Gopcsa L, Masszi T, Tamáska J, Csomor J, Matolcsy A, Tarkovács G, Schönléber J, Kolozsváry F. Myelodysplasia and Multiple Myeloma or Monoclonal Gammopathy. A Non-Fortuitous Coexistence Hungarian Medical Journal. 1: 235-240. DOI: 10.1556/Hmj.1.2007.2.10 |
0.312 |
|
| 2006 |
Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation]. Orvosi Hetilap. 147: 2175-9. PMID 17402211 |
0.699 |
|
| 2006 |
Gagyi E, Horváth E, Bödör C, Timár B, Matolcsy A, Pávai Z. Prognostic significance and detection of the internal tandem duplication of the FLT3 gene in acute myeloid leukemia. Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie. 47: 331-7. PMID 17392978 |
0.793 |
|
| 2006 |
Rossi D, Berra E, Cerri M, Deambrogi C, Barbieri C, Franceschetti S, Lunghi M, Conconi A, Paulli M, Matolcsy A, Pasqualucci L, Capello D, Gaidano G. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma Haematologica. 91: 1405-1409. PMID 17018394 DOI: 10.3324/%%X |
0.469 |
|
| 2006 |
Reiniger L, Bödör C, Bognár A, Balogh Z, Csomor J, Szepesi A, Kopper L, Matolcsy A. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia. 20: 1089-95. PMID 16541139 DOI: 10.1038/Sj.Leu.2404183 |
0.787 |
|
| 2005 |
Gopcsa L, Banyai A, Jakab K, Kormos L, Tamaska J, Matolcsy A, Gogolak P, Rajnavolgyi E, Paloczi K. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells. European Journal of Haematology. 75: 346-51. PMID 16146542 DOI: 10.1111/J.1600-0609.2005.00513.X |
0.381 |
|
| 2005 |
Bognár A, Csernus B, Bödör C, Reiniger L, Szepesi A, Tóth E, Kopper L, Matolcsy A. Clonal selection in the bone marrow involvement of follicular lymphoma. Leukemia. 19: 1656-62. PMID 15973453 DOI: 10.1038/Sj.Leu.2403844 |
0.416 |
|
| 2005 |
Bödör C, Bognár A, Reiniger L, Szepesi A, Tóth E, Kopper L, Matolcsy A. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma. British Journal of Haematology. 129: 373-6. PMID 15842661 DOI: 10.1111/J.1365-2141.2005.05454.X |
0.457 |
|
| 2004 |
Csernus B, Timár B, Fülöp Z, Bognár A, Szepesi A, László T, Jáksó P, Warnke R, Kopper L, Matolcsy A. Mutational analysis of IgVH and BCL-6 genes suggests thymic B-cells origin of mediastinal (thymic) B-cell lymphoma. Leukemia & Lymphoma. 45: 2105-10. PMID 15370257 DOI: 10.1080/1042819042000219467 |
0.788 |
|
| 2004 |
Natkunam Y, Soslow R, Matolcsy A, Dolezal M, Bhargava V, Knowles DM, Warnke R. Immunophenotypic and genotypic characterization of progression in follicular lymphomas. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 12: 97-104. PMID 15354733 DOI: 10.1097/00129039-200406000-00001 |
0.489 |
|
| 2004 |
Takács I, Eros N, Bene I, Bozsó F, Tordai L, Károlyi Z, Radványi G, Matolcsy A. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy. Annals of Hematology. 83: 608-10. PMID 15205915 DOI: 10.1007/S00277-004-0897-0 |
0.344 |
|
| 2004 |
Erös N, Károlyi Z, Matolcsy A. [Complex histologic, immunophenotypic and molecular genetic investigation in cutaneous T-cell lymphoproliferative diseases]. Orvosi Hetilap. 145: 75-80. PMID 14978878 |
0.308 |
|
| 2004 |
Timár B, Fülöp Z, Csernus B, Angster C, Bognár A, Szepesi A, Kopper L, Matolcsy A. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome. Leukemia. 18: 326-30. PMID 14671632 DOI: 10.1038/Sj.Leu.2403249 |
0.764 |
|
| 2003 |
Eros N, Karolyi Z, Kovács A, Matolcsy A, Barna T, Kelényi G. Large B-cell lymphoma of the leg in a patient with multiple malignant tumours. Acta Dermato-Venereologica. 83: 354-7. PMID 14609103 DOI: 10.1080/00015550310010612 |
0.424 |
|
| 2003 |
Szánthó A, Bálega J Já, Csapó Z, Sréter L Lí, Matolcsy A, Papp Z. Primary non-Hodgkin's lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: case report. Gynecologic Oncology. 89: 171-4. PMID 12694673 DOI: 10.1016/S0090-8258(03)00057-X |
0.359 |
|
| 2003 |
Fülöp Z, Csernus B, Tímár B, Szepesi A, Matolcsy A. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. Leukemia. 17: 411-5. PMID 12592341 DOI: 10.1038/Sj.Leu.2402792 |
0.744 |
|
| 2002 |
Gömöri E, Fülöp Z, Mészáros I, Dóczi T, Matolcsy A. Microsatellite analysis of primary and recurrent glial tumors suggests different modalities of clonal evolution of tumor cells. Journal of Neuropathology and Experimental Neurology. 61: 396-402. PMID 12025942 DOI: 10.1093/Jnen/61.5.396 |
0.788 |
|
| 2000 |
Nagy M, Balázs M, Adám Z, Petkó Z, Tímár B, Szereday Z, László T, Warnke RA, Matolcsy A. Genetic instability is associated with histological transformation of follicle center lymphoma. Leukemia. 14: 2142-8. PMID 11187904 DOI: 10.1038/Sj.Leu.2401978 |
0.753 |
|
| 2000 |
Gömöri E, Dóczi T, Pajor L, Matolcsy A. Sporadic p53 mutations and absence of ras mutations in glioblastomas. Acta Neurochirurgica. 141: 593-9. PMID 10929724 DOI: 10.1007/s007010050348 |
0.308 |
|
| 2000 |
Szereday Z, Csernus B, Nagy M, László T, Warnke RA, Matolcsy A. Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma. The American Journal of Pathology. 156: 1017-24. PMID 10702417 DOI: 10.1016/S0002-9440(10)64969-3 |
0.533 |
|
| 2000 |
László T, Nagy M, Kelényi G, Matolcsy A. Immunoglobulin V(H) gene mutational analysis suggests that blastic variant of mantle cell lymphoma derives from different stages of B-cell maturation. Leukemia Research. 24: 27-31. PMID 10634642 DOI: 10.1016/S0145-2126(99)00156-3 |
0.471 |
|
| 1999 |
László T, Matolcsy A. Blastic transformation of mantle cell lymphoma: genetic evidence for a clonal link between the two stages of the tumour. Histopathology. 35: 355-9. PMID 10564390 DOI: 10.1046/J.1365-2559.1999.00745.X |
0.304 |
|
| 1999 |
Matolcsy A. High-grade transformation of low-grade non-Hodgkin's lymphomas: mechanisms of tumor progression. Leukemia & Lymphoma. 34: 251-9. PMID 10439362 DOI: 10.3109/10428199909050950 |
0.426 |
|
| 1999 |
Matolcsy A. Primary effusional lymphoma: A new non-Hodgkin s lymphoma entity. Pathology Oncology Research : Por. 5: 87-9. PMID 10393357 DOI: 10.1053/Paor.1999.0203 |
0.377 |
|
| 1999 |
Matolcsy A, Schattner EJ, Knowles DM, Casali P. Clonal evolution of B cells in transformation from low- to high-grade lymphoma. European Journal of Immunology. 29: 1253-64. PMID 10229093 DOI: 10.1002/(Sici)1521-4141(199904)29:04<1253::Aid-Immu1253>3.0.Co;2-8 |
0.447 |
|
| 1999 |
Sebestyén A, Berczi L, Mihalik R, Paku S, Matolcsy A, Kopper L. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas. British Journal of Haematology. 104: 412-9. PMID 10050727 DOI: 10.1046/J.1365-2141.1999.01211.X |
0.442 |
|
| 1998 |
Matolcsy A, Nádor RG, Cesarman E, Knowles DM. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. The American Journal of Pathology. 153: 1609-14. PMID 9811353 DOI: 10.1016/S0002-9440(10)65749-5 |
0.514 |
|
| 1998 |
Pajor L, Matolcsy A, Vass JA, Méhes G, Marton E, Szabó F, Iványi JL. Phenotypic and genotypic analyses of blastic cell population suggest that pure B-lymphoblastic leukemia may arise from myelodysplastic syndrome. Leukemia Research. 22: 13-7. PMID 9585074 DOI: 10.1016/S0145-2126(97)00131-8 |
0.425 |
|
| 1997 |
Matolcsy A, Casali P, Nádor RG, Liu Y, Knowles DM. Molecular Characterization of IgA- and/or IgG-Switched Chronic Lymphocytic Leukemia B Cells Blood. 89: 1732-1739. DOI: 10.1182/Blood.V89.5.1732.1732_1732_1739 |
0.491 |
|
| 1997 |
Matolcsy A, Warnke R, Knowles D. Somatic mutations of the translocated bcl-2 gene are associated with morphologic transformation of follicular lymphoma to diffuse large-cell lymphoma Annals of Oncology. 8: S119-S122. DOI: 10.1093/annonc/8.suppl_2.S119 |
0.373 |
|
| 1996 |
Matolcsy A, Casali P, Warnke R, Knowles D. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene Blood. 88: 3937-3944. DOI: 10.1182/blood.V88.10.3937.bloodjournal88103937 |
0.413 |
|
| 1995 |
Matolcsy A, Casali P, Knowles DM. Different clonal origin of B-cell populations of chronic lymphocytic leukemia and large-cell lymphoma in Richter's syndrome. Annals of the New York Academy of Sciences. 764: 496-503. PMID 7486574 DOI: 10.1111/J.1749-6632.1995.Tb55872.X |
0.492 |
|
| 1994 |
Matolcsy A, Inghirami G, Knowles D. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma) Blood. 83: 1363-1372. DOI: 10.1182/blood.v83.5.1363.1363 |
0.419 |
|
| 1991 |
Matolcsy A, Kálmán E, Pajor L, Kónya T, Weber E. Morphologic and flow cytometric analysis of circulating megakaryoblasts in chronic myeloid leukaemia. Leukemia Research. 15: 887-97. PMID 1921449 DOI: 10.1016/0145-2126(91)90164-O |
0.398 |
|
| Show low-probability matches. |